Drug Detail

Drug Name Asciminib
Trade Name
Synonyms ABL001
Drug Descriptions

Asciminib (ABL001) is an allosteric inhibitor of BCR-ABL that binds to a unique location outside the ATP binding site, resulting in decreased BCR-ABL kinase activity and reduced tumor growth (Blood Dec 2014, 124 (21) 398).

DrugClasses BCR-ABL Inhibitor 24

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Asciminib Asciminib 0 2
Asciminib + Dasatinib Asciminib Dasatinib 0 0
Asciminib + Dasatinib + Prednisone Asciminib Dasatinib Prednisone 0 1
Asciminib + Imatinib Asciminib Imatinib 0 1
Asciminib + Nilotinib Asciminib Nilotinib 0 0


Additional content available in CKB BOOST